Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Nov 1;21(Supplement_5):v1-v100. doi: 10.1093/neuonc/noz150.

PMID:
31675094
2.

Pilocytic astrocytoma: Where do they belong in cancer reporting?

Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Oct 22. pii: noz202. doi: 10.1093/neuonc/noz202. [Epub ahead of print] No abstract available.

PMID:
31637436
3.

Cancer collection efforts in the United States provide clinically relevant data on all primary brain and other CNS tumors.

Kruchko C, Gittleman H, Ruhl J, Hofferkamp J, Ward EM, Ostrom QT, Sherman RL, Jones SF, Barnholtz-Sloan JS, Wilson RJ.

Neurooncol Pract. 2019 Sep;6(5):330-339. doi: 10.1093/nop/npz029. Epub 2019 Jul 2. Review.

PMID:
31555447
4.

Risk factors for childhood and adult primary brain tumors.

Ostrom QT, Fahmideh MA, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, Bondy ML.

Neuro Oncol. 2019 Nov 4;21(11):1357-1375. doi: 10.1093/neuonc/noz123.

PMID:
31301133
5.

Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

Truitt G, Gittleman H, Leece R, Ostrom QT, Kruchko C, Armstrong TS, Gilbert MR, Barnholtz-Sloan JS.

J Neurooncol. 2019 Aug;144(1):53-63. doi: 10.1007/s11060-019-03215-x. Epub 2019 Jun 17.

PMID:
31209773
6.

Glioma incidence and survival variations by county-level socioeconomic measures.

Cote DJ, Ostrom QT, Gittleman H, Duncan KR, CreveCoeur TS, Kruchko C, Smith TR, Stampfer MJ, Barnholtz-Sloan JS.

Cancer. 2019 Oct 1;125(19):3390-3400. doi: 10.1002/cncr.32328. Epub 2019 Jun 17.

PMID:
31206646
7.

Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma.

Takahashi H, Cornish AJ, Sud A, Law PJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il'yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Turnbull C, Houlston RS.

Sci Rep. 2019 May 23;9(1):7924. doi: 10.1038/s41598-019-43787-2.

8.

Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.

Ascha MS, Ostrom QT, Wright J, Kumthekar P, Bordeaux JS, Sloan AE, Schumacher FR, Kruchko C, Barnholtz-Sloan JS.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):917-925. doi: 10.1158/1055-9965.EPI-18-1116.

PMID:
31053636
9.

Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.

Gittleman H, Cioffi G, Vecchione-Koval T, Ostrom QT, Kruchko C, Osorio DS, Finlay JL, Barnholtz-Sloan JS.

J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25.

PMID:
31025275
10.

Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.

Ostrom QT, Egan KM, Nabors LB, Gerke T, Thompson RC, Olson JJ, LaRocca R, Chowdhary S, Eckel-Passow JE, Armstrong G, Wiencke JK, Bernstein JL, Claus EB, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Amos CI, Huse JT, Barnholtz-Sloan JS, Bondy ML.

Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32318. [Epub ahead of print]

PMID:
30963577
11.

Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.

Dandachi D, Ostrom QT, Chong I, Serpa JA, Giordano TP, Kruchko C, Barnholtz-Sloan JS, Fowler N, Colen RR, Morón FE.

Cancer Causes Control. 2019 May;30(5):477-488. doi: 10.1007/s10552-019-01144-8. Epub 2019 Mar 19.

PMID:
30888569
12.

The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014.

Tish S, Habboub G, Jones J, Ostrom QT, Kruchko C, Barnholtz-Sloan JS, Recinos PF, Kshettry VR.

J Neurooncol. 2019 May;143(1):123-127. doi: 10.1007/s11060-019-03144-9. Epub 2019 Mar 11.

PMID:
30859483
13.

Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma.

Atkins I, Kinnersley B, Ostrom QT, Labreche K, Il'yasova D, Armstrong GN, Eckel-Passow JE, Schoemaker MJ, Nöthen MM, Barnholtz-Sloan JS, Swerdlow AJ, Simon M, Rajaraman P, Chanock SJ, Shildkraut J, Bernstein JL, Hoffmann P, Jöckel KH, Lai RK, Claus EB, Olson SH, Johansen C, Wrensch MR, Melin B, Jenkins RB, Sanson M, Bondy ML, Houlston RS.

Cancer Res. 2019 Apr 15;79(8):2065-2071. doi: 10.1158/0008-5472.CAN-18-2888. Epub 2019 Feb 1.

14.

Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival.

Ostrom QT, Gittleman H, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2019 Mar;142(1):27-38. doi: 10.1007/s11060-018-03073-z. Epub 2018 Dec 12.

PMID:
30543034
15.

Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis.

Amirian ES, Ostrom QT, Armstrong GN, Lai RK, Gu X, Jacobs DI, Jalali A, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut JM, Ali-Osman F, Sadetzki S, Jenkins RB, Lachance DH, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Johansen C, Houlston RS, Scheurer ME, Shete S, Amos CI, Melin B, Bondy ML.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):555-562. doi: 10.1158/1055-9965.EPI-18-0702. Epub 2018 Nov 27.

PMID:
30482874
16.

Epidemiology and Molecular Epidemiology.

Bauchet L, Ostrom QT.

Neurosurg Clin N Am. 2019 Jan;30(1):1-16. doi: 10.1016/j.nec.2018.08.010. Review.

PMID:
30470396
17.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. doi: 10.1093/neuonc/noy131. Review. No abstract available.

18.

Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.

Ostrom QT, Kinnersley B, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Eckel-Passow JE, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M; GliomaScan consortium, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Bondy ML, Barnholtz-Sloan JS.

Int J Cancer. 2018 Nov 15;143(10):2359-2366. doi: 10.1002/ijc.31759. Epub 2018 Sep 19.

PMID:
30152087
19.

Sex-specific gene and pathway modeling of inherited glioma risk.

Ostrom QT, Coleman W, Huang W, Rubin JB, Lathia JD, Berens ME, Speyer G, Liao P, Wrensch MR, Eckel-Passow JE, Armstrong G, Rice T, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M; GliomaScan consortium, Melin B, Bondy ML, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Jan 1;21(1):71-82. doi: 10.1093/neuonc/noy135.

PMID:
30124908
20.

Epidemiology of Brain Tumors.

Barnholtz-Sloan JS, Ostrom QT, Cote D.

Neurol Clin. 2018 Aug;36(3):395-419. doi: 10.1016/j.ncl.2018.04.001. Epub 2018 Jun 15. Review.

PMID:
30072062
21.

A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations.

Makkar N, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

Cancer Med. 2018 Sep;7(9):4773-4780. doi: 10.1002/cam4.1706. Epub 2018 Aug 1.

22.

Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.

Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS.

JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.

23.

Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014.

Gittleman H, Boscia A, Ostrom QT, Truitt G, Fritz Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Nov 9;20(suppl_7):vii6-vii16. doi: 10.1093/neuonc/noy090.

24.

Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

Ostrom QT, Kinnersley B, Wrensch MR, Eckel-Passow JE, Armstrong G, Rice T, Chen Y, Wiencke JK, McCoy LS, Hansen HM, Amos CI, Bernstein JL, Claus EB, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Rubin JB, Lathia JD, Berens ME, Andersson U, Rajaraman P, Chanock SJ, Linet MS, Wang Z, Yeager M; GliomaScan consortium, Houlston RS, Jenkins RB, Melin B, Bondy ML, Barnholtz-Sloan JS.

Sci Rep. 2018 May 9;8(1):7352. doi: 10.1038/s41598-018-24580-z.

25.

Brain tumor biobanking in the precision medicine era: building a high-quality resource for translational research in neuro-oncology.

Ostrom QT, Devine K, Fulop J, Wolinsky Y, Liao P, Stetson L, Couce M, Sloan AE, Barnholtz-Sloan JS.

Neurooncol Pract. 2017 Dec;4(4):220-228. doi: 10.1093/nop/npw029. Epub 2016 Dec 30. Review. Erratum in: Neurooncol Pract. 2017 Jun;4(2):136.

26.

Impact of atopy on risk of glioma: a Mendelian randomisation study.

Disney-Hogg L, Cornish AJ, Sud A, Law PJ, Kinnersley B, Jacobs DI, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il'yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS.

BMC Med. 2018 Mar 15;16(1):42. doi: 10.1186/s12916-018-1027-5.

27.

Influence of obesity-related risk factors in the aetiology of glioma.

Disney-Hogg L, Sud A, Law PJ, Cornish AJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il'yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Swerdlow AJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS.

Br J Cancer. 2018 Apr;118(7):1020-1027. doi: 10.1038/s41416-018-0009-x. Epub 2018 Mar 13.

28.

Females have the survival advantage in glioblastoma.

Ostrom QT, Rubin JB, Lathia JD, Berens ME, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Mar 27;20(4):576-577. doi: 10.1093/neuonc/noy002. No abstract available.

29.

The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone.

Kruchko C, Ostrom QT, Gittleman H, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Feb 19;20(3):295-298. doi: 10.1093/neuonc/noy006. No abstract available.

30.

Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence.

Liao P, Ostrom QT, Stetson L, Barnholtz-Sloan JS.

Neuro Oncol. 2018 Jun 18;20(7):942-953. doi: 10.1093/neuonc/noy003.

31.

Mendelian randomisation study of the relationship between vitamin D and risk of glioma.

Takahashi H, Cornish AJ, Sud A, Law PJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il'yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Turnbull C, Houlston RS.

Sci Rep. 2018 Feb 5;8(1):2339. doi: 10.1038/s41598-018-20844-w. Erratum in: Sci Rep. 2019 May 23;9(1):7924.

32.

Brain metastases: epidemiology.

Ostrom QT, Wright CH, Barnholtz-Sloan JS.

Handb Clin Neurol. 2018;149:27-42. doi: 10.1016/B978-0-12-811161-1.00002-5. Review.

PMID:
29307358
33.

Epidemiology of Intracranial Gliomas.

Ostrom QT, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan JS.

Prog Neurol Surg. 2018;30:1-11. doi: 10.1159/000464374. Epub 2017 Dec 14. Review.

PMID:
29241168
34.

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88. doi: 10.1093/neuonc/nox158. No abstract available.

35.

The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.

Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C.

Neuro Oncol. 2018 Apr 9;20(5):687-694. doi: 10.1093/neuonc/nox187.

36.

Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.

Khanna V, Achey RL, Ostrom QT, Block-Beach H, Kruchko C, Barnholtz-Sloan JS, de Blank PM.

J Neurooncol. 2017 Dec;135(3):433-441. doi: 10.1007/s11060-017-2594-6. Epub 2017 Aug 21.

PMID:
28828582
37.

Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Gittleman H, Cote DJ, Ostrom QT, Kruchko C, Smith TR, Claus EB, Barnholtz-Sloan JS.

J Neurooncol. 2017 Sep;134(2):269-277. doi: 10.1007/s11060-017-2543-4. Epub 2017 Jun 30.

PMID:
28667594
38.

Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.

Kromer C, Xu J, Ostrom QT, Gittleman H, Kruchko C, Sawaya R, Barnholtz-Sloan JS.

J Neurooncol. 2017 Aug;134(1):55-64. doi: 10.1007/s11060-017-2516-7. Epub 2017 May 31.

PMID:
28567587
39.

Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.

Karimi S, Vyas MV, Gonen L, Tabasinejad R, Ostrom QT, Barnholtz-Sloan J, Suppiah S, Zadeh G, Aldape K.

Neuro Oncol. 2017 Oct 19;19(11):1503-1510. doi: 10.1093/neuonc/nox089.

40.

Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007.

Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2017 Oct 19;19(11):1553-1564. doi: 10.1093/neuonc/nox091.

41.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75. doi: 10.1093/neuonc/now207. No abstract available.

PMID:
28475809
42.

Is mortality due to primary malignant brain and other central nervous system tumors decreasing?

Gittleman H, Kromer C, Ostrom QT, Blanda R, Russell J, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2017 Jun;133(2):265-275. doi: 10.1007/s11060-017-2449-1. Epub 2017 May 3.

PMID:
28470430
43.

Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.

Achey RL, Khanna V, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2017 May;133(1):17-25. doi: 10.1007/s11060-017-2414-z. Epub 2017 Apr 10.

PMID:
28397028
44.

Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors.

Melin BS, Barnholtz-Sloan JS, Wrensch MR, Johansen C, Il'yasova D, Kinnersley B, Ostrom QT, Labreche K, Chen Y, Armstrong G, Liu Y, Eckel-Passow JE, Decker PA, Labussière M, Idbaih A, Hoang-Xuan K, Di Stefano AL, Mokhtari K, Delattre JY, Broderick P, Galan P, Gousias K, Schramm J, Schoemaker MJ, Fleming SJ, Herms S, Heilmann S, Nöthen MM, Wichmann HE, Schreiber S, Swerdlow A, Lathrop M, Simon M, Sanson M, Andersson U, Rajaraman P, Chanock S, Linet M, Wang Z, Yeager M; GliomaScan Consortium, Wiencke JK, Hansen H, McCoy L, Rice T, Kosel ML, Sicotte H, Amos CI, Bernstein JL, Davis F, Lachance D, Lau C, Merrell RT, Shildkraut J, Ali-Osman F, Sadetzki S, Scheurer M, Shete S, Lai RK, Claus EB, Olson SH, Jenkins RB, Houlston RS, Bondy ML.

Nat Genet. 2017 May;49(5):789-794. doi: 10.1038/ng.3823. Epub 2017 Mar 27.

45.

Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.

Zhang AS, Ostrom QT, Kruchko C, Rogers L, Peereboom DM, Barnholtz-Sloan JS.

Neuro Oncol. 2017 May 1;19(5):726-735. doi: 10.1093/neuonc/now252.

46.

Integrated genomic analysis of survival outliers in glioblastoma.

Peng S, Dhruv H, Armstrong B, Salhia B, Legendre C, Kiefer J, Parks J, Virk S, Sloan AE, Ostrom QT, Barnholtz-Sloan JS, Tran NL, Berens ME.

Neuro Oncol. 2017 Jun 1;19(6):833-844. doi: 10.1093/neuonc/now269. Erratum in: Neuro Oncol. 2017 Apr 1;19(4):601.

47.

Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).

Ostrom QT, Gittleman H, Kruchko C, Louis DN, Brat DJ, Gilbert MR, Petkov VI, Barnholtz-Sloan JS.

J Neurooncol. 2016 Oct;130(1):31-42. Epub 2016 Jul 14.

48.

Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry.

Chien LN, Gittleman H, Ostrom QT, Hung KS, Sloan AE, Hsieh YC, Kruchko C, Rogers LR, Wang YF, Chiou HY, Barnholtz-Sloan JS.

Front Public Health. 2016 Jul 21;4:151. doi: 10.3389/fpubh.2016.00151. eCollection 2016.

49.

Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012.

Farah P, Blanda R, Kromer C, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

J Neurooncol. 2016 Jul;128(3):419-29. doi: 10.1007/s11060-016-2127-8. Epub 2016 Apr 19.

PMID:
27095247
50.

Understanding inherited genetic risk of adult glioma - a review.

Rice T, Lachance DH, Molinaro AM, Eckel-Passow JE, Walsh KM, Barnholtz-Sloan J, Ostrom QT, Francis SS, Wiemels J, Jenkins RB, Wiencke JK, Wrensch MR.

Neurooncol Pract. 2016 Mar;3(1):10-16. Epub 2015 Aug 25.

Supplemental Content

Loading ...
Support Center